Drimva

Novartis

Senior Scientist I/II, Hematology- Target Biology and Discovery

$94K–$183K

Cambridge (USA) · Senior · Full-time · Posted Oct 28, 2026

Experience
3-5 years of relevant laboratory experience.
Education
Bachelor’s or master’s degree in biology, cellular or molecular biology, or a related scientific discipline.

About the job

Conduct target biology and discovery research to identify and validate therapeutic targets and advance early drug-discovery programs for hematologic cancers, particularly myeloid malignancies.

What you'll do

  • Design and conduct studies on target identification, target validation, and mechanism of action using molecular and cellular approaches.
  • Develop cellular assays and use disease-relevant hematologic models to address drug-discovery questions.
  • Analyze and communicate results, contribute to project strategy, and maintain laboratory safety and documentation.

What they ask for

  • Bachelor’s or master’s degree in biology, cellular or molecular biology, or a related scientific discipline.
  • Hands-on experience designing, executing, and interpreting molecular and cellular biology experiments, including developing reproducible cellular assays.
  • Proficiency in mammalian cell culture and molecular and protein-analysis methods such as cloning, qPCR, western blotting, and multiparameter flow cytometry.
  • Ability to plan and troubleshoot experiments and communicate conclusions; strong scientific communication, organization, and collaboration skills.

Nice to have

  • Experience with primary hematopoietic, immune, or patient-derived samples; CRISPR-based functional genomics; or medium- or high-throughput screening or profiling.
  • Experience in pharmaceutical, biotechnology, or translational research, or familiarity with hematologic malignancies, particularly AML or MDS.

Pay

$93,800 - $174,200 (base salary); $98,700 - $183,400 (base salary)

Tools

CRISPR-based perturbation, gene knockdown/overexpression, chemical probes, western blotting, qPCR, imaging, cellular phenotyping, multiparameter flow cytometry

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 6, 2026 (UTC)